Analyst Research

Report Title Price
Thomson Reuters Stock Report - IL DONG PHARMACEUTICAL COMPANY LIMITED (000230-SE)
Provider: Thomson Reuters Stock Report
$25.00
Buy
Wright Investors Service Comprehensive Report for Il Dong Pharmaceutical Company Limited
Provider: Wright Reports
$483.00
Buy
Ildong Pharmaceutical Co Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
$20.00
Buy
Ildong Pharmaceuticals Co. Ltd. (000230) - Financial Analysis Review
Provider: GlobalData
$125.00
Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

» More Analyst Research

Ildong Pharmaceutical Co., Ltd. Declares Annual Cash Dividend for FY 2012


Monday, 25 Feb 2013 03:09am EST 

Ildong Pharmaceutical Co., Ltd. announced that it has declared an annual cash dividend of KRW 150 per share of common stock to shareholders of record on December 31, 2012, for the fiscal year 2012. The dividend rate of market price is 1.31% and the total amount of the cash dividend is KRW 3,635,473,500. The Company's annual cash dividend for the fiscal year 2011 was KRW 180 per share. 

Latest Developments for Ildong Pharmaceutical Co Ltd

Latest Key Developments in Pharmaceuticals

Company Quote

Ildong Pharmaceutical Co Ltd
(000230.KS)
12050.0
500.0 +4.33%
24 May 2013